KIAA1324 suppresses gastric cancer progression by inhibiting the oncoprotein GRP78

Cancer Research

Volumn 75, Issue 15, 2015, Pages 3087-3097

  Kang, Jin Muk ^a   Park, Sujin ^a   Kim, Staci Jakyong ^a,b   Kim, Hyojung ^a   Lee, Bona ^a,c   Kim, Junil ^a   Park, Jinah ^a   Kim, Shin Tae ^a   Yang, Han Kwang ^d,e   Kim, Woo Ho ^d,e   Kim, Seong Jin ^a  

^a CHA University   (South Korea)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Sookmyung Women's University   (South Korea)

^d Seoul National University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; HISTONE DEACETYLASE; HEAT SHOCK PROTEIN; KIAA1324 PROTEIN, HUMAN; MOLECULAR CHAPERONE GRP78; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIAA1324 GENE; MALE; PRIORITY JOURNAL; STOMACH CANCER; TISSUE MICROARRAY; TRANSCRIPTOMICS; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; CASE CONTROL STUDY; DRUG SCREENING; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUSE; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; STOMACH TUMOR; TUMOR CELL LINE;

AGED; ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN STRUCTURE, TERTIARY; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84942887947     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3751     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D., Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009; 374: 477-90.
3. Wang K, Yuen ST, Xu J, Lee S.P., Yan HH, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 2014; 46: 573-82.
4. Liang H, Kim YH Identifying molecular drivers of gastric cancer through next-generation sequencing. Cancer Lett 2013; 340: 241-6.
5. Lee HK, Xiang C, Cazacu S., Finniss S, Kazimirsky G, Lemke N., et al. GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro Oncol 2008; 10: 236-43.
6. Zheng HC, Takahashi H, Li X.H., Hara T., Masuda S, Guan YF, et al Over-expression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol 2008; 39: 1042-9.
7. Fernandez PM, Tabbara SO, Jacobs L.K., Manning FC, Tsangaris TN, Schwartz AM, et al Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 2000; 59: 15-26.
8. Thornton M, Aslam MA, Tweedle E.M., Ang C., Campbell F, Jackson R, et al The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer. Int J Cancer 2013; 133: 1408-18.
9. Reddy RK, Mao C, Baumeister P., Austin RC, Kaufman RJ, Lee AS. Endo-plasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003; 278: 20915-24.
10. Fu Y, Li J, Lee AS GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res 2007; 67: 3734-40.
11. Little E, Ramakrishnan M, Roy B., Gazit G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr 1994; 4: 1-18.
12. Arap MA, Lahdenranta J, Mintz P.J., Hajitou A., Sarkis AS, Arap W, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004; 6: 275-84.
13. Zhang Y, Liu R, Ni M., Gill P, Lee AS. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem 2010; 285: 15065-75.
14. Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P, et al. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci U S A 2008; 105: 19444-9.
15. Zhang Y, Tseng CC, Tsai Y.L., Fu X., Schiff R, Lee AS. Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PLoS ONE 2013; 8: e80071.
16. Kang J, Zhao G, Lin T., Tang S, Xu G, Hu S., et al. A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells. Cancer Lett 2013; 339: 247-59.
17. Lee AS. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer 2014; 14: 263-76.
18. Cheng CC, Lu N, Peng C.L., Chang CC, Mai FD, Chen LY, et al Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system. Proteomics 2012; 12: 2584-97.
19. Wu JY, Cheng CC, Wang J.Y., Wu DC, Hsieh JS, Lee SC, et al Discovery of tumor markers for gastric cancer by proteomics. PLoS ONE 2014; 9: e84158.
20. Tsutsumi S, Namba T, Tanaka K.I., Arai Y., Ishihara T, Aburaya M, et al Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene 2006; 25: 1018-29.
21. Deng L, Broaddus RR, McCampbell A, Shipley G.L., Loose DS, Stancel GM, et al. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin Cancer Res 2005; 11: 8258-64.
22. Schlumbrecht MP, Xie SS, Shipley G.L., Urbauer DL, Broaddus RR. Molecular clustering based on ERalpha and EIG121 predicts survival in highgrade serous carcinoma of the ovary/peritoneum. Mod Pathol 2011; 24: 453-62.
23. Estrella JS, Ma LT, Milton D.R., Yao JC, Wang H, Rashid A, et al Expression of estrogen-induced genes and estrogen receptor beta in pancreatic neuroendocrine tumors: implications for targeted therapy. Pancreas 2014; 43: 996-1002.
24. Deng L, Feng J, Broaddus RR The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death Dis 2010; 1: e32.
25. Kang JM, Park S, Kim S.J., Hong HY, Jeong J, Kim HS. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-beta signaling. Oncogene 2012; 31: 5123-31.
26. Yoon K, Lee S, Han T.S., Moon SY, Yun SM, Kong SH, et al Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Res 2013; 23:1109-17.
27. Nagase T, Koga H, Ohara O. Kazusa mammalian cDNA resources: towards functional characterization of KIAA gene products. Brief Funct Genomic Proteomic 2006; 5: 4-7.
28. Khanna A, Bockelman C, Hemmes A., Junttila MR, Wiksten JP, Lundin M, et al MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 2009; 101: 793-805.
29. Cho JY, Lim JY, Cheong J.H., Park YY, Yoon SL, Kim SM, et al Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res 2011; 17: 1850-7.
30. Cameron EE, Bachman KE, Myohanen S, Herman J.G., Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999; 21: 103-7.
31. Klockenbusch C, Kast J. Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol 2010; 2010: 927585.
32. Wei J, Gaut JR, Hendershot LM In vitro dissociation of BiP-peptide complexes requires a conformational change in BiP after ATP binding but does not require ATP hydrolysis. J Biol Chem 1995; 270: 26677-82.
33. Zhao Q, Kirkness EF, Caballero O.L., Galante PA, Parmigiani RB, Edsall L, et al Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol 2010; 11: R114.
34. Liu J, Huang Y, Kumar A., Tan A, Jin S, Mozhi A., et al. pH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv 2014; 32: 693-710.
35. Kasala D, Choi JW, Kim S.W., Yun CO. Utilizing adenovirus vectors for gene delivery in cancer. Expert Opin Drug Deliv 2014; 11: 379-92.
36. Kelber JA, Panopoulos AD, Shani G, Booker E.C., Belmonte JC, Vale WW, et al. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene 2009; 28: 2324-36.
37. Li Z, Zhang L, Zhao Y., Li H, Xiao H, Fu R., et al. Cell-surface GRP78 facilitates colorectal cancer cell migration and invasion. Int J Biochem Cell Biol 2013; 45: 987-94.
38. Zhang XX, Li HD, Zhao S, Zhao L., Song HJ, Wang G, et al. The cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cells. Biomed Res Int 2013; 2013: 917296.
39. Shin BK, Wang H, Yim A.M., Le Naour F, Brichory F, Jang J.H., et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 2003; 278: 7607-16.
40. Davidson DJ, Haskell C, Majest S., Kherzai A, Egan DA, Walter K.A., et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res 2005; 65: 4663-72.
41. Gonzalez-Gronow M., Cuchacovich M, Llanos C., Urzua C, Gawdi G, Pizzo SV Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res 2006; 66: 11424-31.
42. Burikhanov R, Zhao Y, Goswami A., Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 2009; 138: 377-88.
43. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9: 1004-10.
44. Yu L, Wan F, Dutta S., Welsh S, Liu Z, Freundt E., et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci U S A 2006; 103: 4952-7.
45. Wang L, Yu C, Lu Y., He P, Guo J, Zhang C., et al. TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis. Apoptosis 2007; 12: 1489-502.
46. Li C, Wei J, Li Y., He X, Zhou Q, Yan J., et al. Transmembrane Protein 214 (TMEM214) mediates endoplasmic reticulum stress-induced caspase 4 enzyme activation and apoptosis. J Biol Chem 2013; 288: 17908-17.
47. Xu D, Yang F, He H., Hu J, Lv X, Ma D., et al. Expression of TMEM166 protein in human normal and tumor tissues. Appl Immunohistochem Mol Morphol 2013; 21: 543-52.
48. Chang Y, Li Y, Hu J., Guo J, Xu D, Xie H., et al. Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo. Cancer Lett 2013; 328: 126-34.
49. Altomare DA, Testa JR Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005; 24: 7455-64.